Bone marrow failure syndromes can be associated with abnormalities of the forearms. We observed a neonate with congenital thrombocytopenia who had bilateral radio-ulnar synostosis and fifth finger clinodactly. We performed an evaluation of the mechanism causing the thrombocytopenia using a combination of direct and indirect measures of thrombopoiesis. These tests indicated decreased platelet production. This entity of congenital hyporegenerative thrombocytopenia with bilateral radio-ulnar synostosis and fifth-finger clinodactly is an uncommon but easily recognizable form of congenital amegakaryocytic thrombocytopenia (CAMT). This entity can be distinguished from the TAR syndrome (thrombocytopenia and absent radii) by the distinctive orthopedic issues, different underlying genetic mutations, and a more worrisome prognosis for CAMT than for TAR.
INTRODUCTION
Congenital abnormalities of the upper extremities can be associated with bone marrow failure syndromes.
1,2 Thompson et al. 3 recently described four patients with proximal radio-ulnar synostosis and congenital amegakaryocytic thrombocytopenia (CAMT). 3 We observed a neonate with findings similar to the four patients reported by Thompson, and evaluated the mechanism causing the thrombocytopenia using a circulating megakaryocyte progenitor cell assay, plasma thrombopoietin concentration, immunohistochemical staining of megakaryocytes on marrow biopsy, and reticulated platelet percentage. The tests indicated that the thrombocytopenia was the result of reduced platelet production. CAMT with radio-ulnar synostosis should be recognized as a cause of prolonged and severe neonatal thrombocytopenia. This entity is distinct from TAR syndrome and has a more worrisome prognosis.
CASE REPORT
Baby girl N was delivered vaginally at 37 weeks' gestation to a healthy 31-year-old mother, gravida 3, para 0, AB 2 (spontaneous).
Although not recognized at the time of delivery, the mother had bilateral radio-ulnar synostosis, bilateral clinodactily of the fifth fingers, and mild asymptomatic thrombocytopenia (platelet count 135,000/ml). Apgar scores were 8 and 9 at 1 and 5 minutes and birth weight was 2640 g. Multiple scattered petechiae were noted shortly after birth, prompting a platelet count that was 44,000/ml. The hematocrit was 39% and the leukocyte concentration was 17,000/ml. She otherwise appeared well and had no hepatosplenomegaly, lymphadenopathy, or obvious dysmorphic features. Ampicillin and Cefotaxime were administered after blood cultures were drawn but were discontinued after 72 hours because cultures were negative and no signs of infection were present.
Additional laboratory evaluation for the thrombocytopenia included a PT, which was 12.6 seconds, and an aPTT, which was 35.8 seconds. A repeat platelet count at 12 hours of age was 9000/ ml and this was immediately repeated with a result of 5000/ml. Thereafter 15 ml/kg of single-donor platelets were transfused. The post-transfusion platelet count was 162,000/ml. Over the next 5 days, the platelet count gradually diminished to 14,000/ml and a second platelet transfusion was given. The following morning the count was 119,000/ml. Evaluation for neonatal alloimmune thrombocytopenia was negative; the mother was PLA-1 positive (HPA-1a) and had a negative antiplatelet antibody screen. The neonate's serum also had a negative antiplatelet antibody screen. Urine cultures for CMV and IgM titers for CMV, Rubella, and Toxoplasmosis were negative.
Over the next 5 weeks, five platelet transfusions were given. Post-transfusion counts invariably increased to >150,000/ml, but over a period of 7 to 8 days the counts gradually diminished to <20,000/mL. Petechiae and occult blood and small amounts of obvious blood were noted in the stools near nadir counts. At 7 weeks she was evaluated for severe and prolonged thrombocytopenia using a research protocol (NIH-HL-69990). She had scattered petechiae, bilateral clinodactily, and restricted pronation at the wrists. X-rays of the arms substantiated the physical examination finding of bilateral proximal radio-ulnar synostosis (Figure 1 ). The plasma thrombopoietin (Tpo) concentration was very high, 1260 pg/ml (162 pg/ml is the value we reported as upper limit of normal for neonates). 4 The circulating megakaryocyte progenitor cell concentration was strikingly low, with only one colony per 5 Â 10 5 light density mononuclear cells plated in recombinant Tpo. 5 The paucity of circulating megakaryocyte progenitors is consistent with reduced platelet production due to reduced progenitors. Indeed, the marrow biopsy was abnormal, with no megakaryocytes identified. The reticulated platelet percentage was low at 0.6% (we consider <1 indicative of decreased platelet production). 6, 7 Reticulated platelets are identified by RNA content, using flow cytometry, and thus the test is analogous to the reticulocyte count for erythrocytes. The low reticulated platelet count is consistent with the paucity of circulating megakaryocyte progenitors and marrow megakaryocytes, indicating that reduced platelet production was the kinetic cause of the thrombocytopenia.
At 8 weeks of age she had a normal cranial ultrasound and was discharged home with a platelet count of 59,000/ml (3 days after a platelet transfusion) and a hematocrit of 29%. She had received eight platelet transfusions during her first 8 weeks of life. One week later she was seen in the Pediatric Hematology/Oncology clinic where she was found to be pancytopenic and was admitted to the hospital. A bone marrow biopsy showed 70% cellularity and absent megakaryocytes by H/E or by anti-CD61 staining (Figure 2 ). She was started on recombinant granulocyte colony-stimulating factor and recombinant erythropoietin for neutropenia and anemia and was discharged home with weekly platelet transfusions. At 4 months of age her bone marrow biopsy showed marked hypocellularity (5%) and absent megakaryocytes. Chromosomal fragility testing was normal excluding Fanconi anemia. She died of a sudden overwhelming infection following stem cell transplantation.
DISCUSSION
Thrombocytopenia in a neonate can be the result of reduced platelet production, excessive platelet destruction or utilization, Photomicrograph of the patient's bone marrow biopsy stained with an anti-CD61 monoclonal antibody, illustrating absence of megakaryocytes ( Â 100). The inset is a bone marrow biopsy from a hematologically normal adult that was included in the same staining run, as a positive control. It demonstrates strong brown cytoplasmic staining in a typical megakaryocyte ( Â 400).
platelet sequestration, or a combination of these mechanisms. The thrombocytopenia in our patient was the result of reduced platelet production. Evidence for this includes the adequate clinical response to platelet transfusions, few circulating megakaryocyte progenitors, absent megakaryocytes on marrow biopsy, and the low reticulated platelet count.
Neonates with severe and prolonged hyporegenerative thrombocytopenia, accompanied by bilaterally absent radii, but with thumbs present bilaterally, have TAR syndrome.
1,2 Other neonates with severe and prolonged hyporegenerative thrombocytopenia but lacking the orthopedic problems that characterize TAR syndrome are generally classified as having CAMT. 1, 8 Our patient, like the four cases recently described by Thompson 4 all of whom had upper extremity abnormalities, but very different orthopedic problems than TAR, has a condition more analogous to CAMT than to TAR. We maintain that the syndrome of congenital thrombocytopenia and radio-ulnar synostosis should be classified as a distinct subtype of CAMT.
Patients with TAR syndrome have normal Tpo production and normal Tpo receptors, but they have a defect in post-receptorbinding responsiveness to Tpo. 1, 2, 9 In contrast, patients with CAMT have various mutations in the Tpo receptor gene and, like our patient, have very high plasma Tpo concentrations. 8, 10, 11 The natural history of TAR differs from that of CAMT; after the first year of life patients with TAR often improve hematologically but those with CAMT often develop bi-or trilineage marrow failure, like our patient did. Perhaps Tpo receptor abnormalities result in marrow failure because of the involvement of Tpo in the regulation of early hematopoiesis.
The high plasma Tpo concentration in our patient, and typical of CAMT, is likely the result of poor binding of Tpo to an abnormal receptor. The resulting small megakaryocyte mass and small platelet mass is insufficient to bind the Tpo that is constitutively produced in the liver, thus resulting in very high plasma Tpo concentrations. 12 The reason for the association between radio-ulnar synostosis and CAMT is not known, but it might relate to mutations in genes such as the Hox family that encode proteins involved in both bone morphology and megakaryopoiesis. 13 Indeed, Thompson and Nguyen 14 recently reported a single base-pair deletion in HoxA11 resulting in a truncated protein, among at least two of their four patients with radio-ulnar synostosis and thrombocytopenia. Our studies, using indirect measures, lead to the assumption that this condition involves a defect in the Tpo receptor. Neonatologists caring for patients with severe and prolonged congenital thrombocytopenia should consider this newly described entity of CAMT with radio-ulnar synostosis by specifically looking for bilateral restricted wrist pronation with fifth finger clinodactly.
